Exhibit 99.1

Doximity Announces Fiscal 2026 Third Quarter Financial Results

Total revenues of $185.1 million, up 10% year-over-year

Net income of $61.6 million, margin of 33%

Adjusted EBITDA of $111.4 million, margin of 60%

Fiscal 2026 Third Quarter Financial Highlights

Financial Outlook

Stock Repurchase Program

Conference Call Information

About Doximity

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Media Contact:

DOXIMITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

			December 31, 2025						March 31, 2025
Assets
Current assets:
Cash and cash equivalents			$	64,838					$	209,614
Marketable securities			670,288						706,050
Accounts receivable, net			156,589						128,354
Prepaid expenses and other current assets			101,738						44,602
Total current assets			993,453						1,088,620
Property and equipment, net			17,055						13,656
Deferred income tax assets			14,842						60,014
Operating lease right-of-use assets			7,523						8,886
Intangible assets, net			37,266						23,072
Goodwill			84,973						67,940
Other assets			1,914						2,121
Total assets			$	1,157,026					$	1,264,309
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable			$	4,785					$	1,356
Accrued expenses and other current liabilities			76,677						38,405
Deferred revenue, current			66,307						114,285
Operating lease liabilities, current			2,079						2,211
Total current liabilities			149,848						156,257
Deferred revenue, non-current			174						280
Operating lease liabilities, non-current			8,613						10,185
Contingent earn-out consideration liability, non-current			—						5,579
Other liabilities, non-current			19,093						9,383
Total liabilities			177,728						181,684
Stockholders' Equity
Preferred stock			—						—
Common stock			185						189
Additional paid-in capital			956,744						894,225
Accumulated other comprehensive income			1,396						1,323
Retained earnings			20,973						186,888
Total stockholders’ equity			979,298						1,082,625
Total liabilities and stockholders’ equity			$	1,157,026					$	1,264,309

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

			Three Months Ended December 31,												Nine Months Ended December 31,
			2025						2024						2025						2024
Cash flows from operating activities
Net income			$	61,558					$	75,196					$	176,937					$	160,727
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			3,989						2,655						10,252						7,830
Deferred income taxes			—						1,992						—						2,196
Stock-based compensation, net of amounts capitalized			33,546						19,368						84,885						54,326
Non-cash lease expense			459						441						1,363						1,392
Accretion of discount on marketable securities, net			(1,764)						(3,368)						(6,451)						(8,736)
Amortization of deferred contract costs			2,499						1,785						9,271						6,544
Impairment of long-lived assets			—						—						—						2,304
Other			295						411						181						289
Changes in operating assets and liabilities:
Accounts receivable			(27,614)						(12,986)						(28,599)						(36,464)
Prepaid expenses and other assets			(12,828)						1,303						(9,377)						21,251
Deferred contract costs			(6,710)						(5,853)						(11,259)						(9,069)
Accounts payable, accrued expenses and other liabilities			41,855						9,418						39,522						3,872
Deferred revenue			(33,816)						(24,628)						(48,084)						(30,085)
Operating lease liabilities			(578)						(545)						(1,705)						(1,599)
Net cash provided by operating activities			60,891						65,189						216,936						174,778
Cash flows from investing activities
Cash paid for acquisition, net of cash acquired			—						—						(26,528)						—
Purchases of intangible assets			(62)						—						(62)						—
Internal-use software development costs			(2,313)						(1,771)						(6,648)						(5,018)
Purchases of marketable securities			(112,922)						(164,025)						(381,122)						(531,833)
Maturities of marketable securities			143,136						99,308						413,167						517,221
Sales of marketable securities			10,386						7,564						10,386						14,805
Net cash provided by (used in) investing activities			38,225						(58,924)						9,193						(4,825)
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants			2,221						3,662						7,017						13,905
Proceeds from issuance of common stock in connection with the employee stock purchase plan			—						—						1,816						1,422
Taxes paid related to net share settlement of equity awards			(8,869)						(8,107)						(33,362)						(16,329)
Repurchase of common stock			(196,879)						(19,307)						(341,127)						(93,505)
Payment of contingent consideration related to a business combination			—						—						(5,249)						(5,470)
Payment of excise taxes on share repurchases			—						(1,491)						—						(1,491)
Net cash used in financing activities			(203,527)						(25,243)						(370,905)						(101,468)
Net increase (decrease) in cash and cash equivalents			(104,411)						(18,978)						(144,776)						68,485
Cash and cash equivalents, beginning of period			169,249						184,248						209,614						96,785
Cash and cash equivalents, end of period			$	64,838					$	165,270					$	64,838					$	165,270
Supplemental disclosures of cash flow information
Cash paid for taxes, net of refunds			$	1,675					$	13,829					$	21,022					$	35,814

Non-GAAP Financial Measures

Key Business Metrics

Reconciliation of GAAP to Non-GAAP Financial Measures